Abstract:OBJECTIVE:To investigate the protein expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter protein 1 (Glut-1) in renal cancer and bladder cancers and the clinical significance thereof.METHODS:TransAMTMELISA was used to detect the protein expression of HIF-1alpha in the tissue sections from 25 patients with bladder transitional cell carcinoma (TCC) and 16 patients with renal clear cell carcinoma resected during operation and small amounts of normal renal and bladder tissues far from the cancer tissue resected simultaneously. Immunohistochemistry was used to detect the protein expression of Glut-1 in tissue sections from 58 patients with bladder carcinoma transitional cell carcinoma and 38 patients with renal clear cell carcinoma resected during operation. 16 specimens of normal bladder and 16 specimens of normal renal tissue were obtained from the patients with other diseases who underwent operation during the same period to be used as controls. Follow-up was conducted for more than 2 years for all patients.RESULTS:The protein expression of HIF-1alpha in the tissue of renal clear cell carcinoma was 3.38 +/- 1.71 microg/well, significantly higher than that in the tissue near the cancer (2.23 +/- 1.07 microg/well, P < 0.01). The protein expression of HIF-1alpha in the bladder TCC tissue was 2.69 +/- 1.34 microg/well, not significantly different from that in the tissue near the cancer (248 +/- 1.28 microg/well, P = 0.60). Protein expression of Glut-1 was not detected in the normal renal and bladder tissues, however, was significantly higher in the bladder TCC and renal clear cell carcinoma tissues. The positive rate of Glut-1 in the bladder TCC tissue was 77.90% (45/58). The positive rates of Glut-1 in the tissues of bladder TCC tissue, grades G1, G2, and G3 were 66.7%, 89.1%, and 53.3%. (P = 0.29), showing the correlation of Glut-1 expression with the grading of cancer. The positive rate of Glut-1 in the superficial TCC was 83.9%, not significantly different from that of the invasive TVV (70.4%, P = 0.90), showing that the Glut-1 is not correlated with the cancer staging. Nineteen of the 31 cases of superficial TCC showed recurrence within 2 years, however, the protein expression of Glut-1 rate was not significantly different between those with recurrence and those without recurrence (P = 0.90), showing that the protein expression of Glut-1 is not correlated with the recurrence of TCC. The protein expression of Glut-1 in the renal clear cell carcinoma was at a rate of 86.9% (33/38), however, it was not correlated with the grade and stage of the cancer.CONCLUSION:The protein expression of HIF-1alpha is strongly associated with the neoplastic progression of renal clear cell carcinoma, but its role in the development of bladder TCC is not clear yet. The protein expression of Glut-1 is strongly associated with the neoplastic progression of bladder TCC and renal clear cell carcinoma.

Expression of PIAS3 in human bladder cancer and normal bladder transitional epithelium and its significance

Expression of PIAS3 an Inhibitor of Activated STAT3 Protein in Human Prostate Cancer

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Overexpression of the ASPM Gene is Associated with Aggressiveness and Poor Outcome in Bladder Cancer.

Pan-cancer Analysis of STAT3 Indicates Its Potential Prognostic Value and Correlation with Immune Cell Infiltration in Prostate Cancer

Expression of PSCA protein in human bladder urothelial cancer and its clinical significance

Effects of PIAS3 Overexpression on Proliferation and Apoptosis in Human Prostate Carcinoma Cell Line DU145

Expressions and clinical significances of PTEN and P53 gene in non-muscle-invasive bladder cancer

Insulin-like Growth Factor Ⅱ Mrna Binding Protein 3 Expression in the Non-Muscle Invasive Bladder Cancer and Its Relationships with the Prognosis

Expression of Oct4 Protein in Non-Muscle-invasive Bladder Cancer

[Expression of PAK1 in Bladder Cancer and Its Influence on Invasion of Bladder Cancer Cells].

Expression of urea transporter B in human bladder cancer tissue and its clinical significance

Expression of p-STAT3 and E-cadherin in pancreatic cancer and their clinical significances

Protein Inhibitor of Activated STAT-1 is Downregulated in Gastric Cancer Tissue and Involved in Cell Metastasis.

[Expression of Hypoxia Inducible Factor-1Alpha and Glucose Transporter Protein 1 in Renal and Bladder Cancers and the Clinical Significance Thereof].

Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy

Expression of CXCR7 Protein in Human Bladder Cancer and Its Clinical Significance

Expression and clinical significance of HMGA2 protein in urothelial bladder cancer

Expression of PCNA in Human Bladder Transitional Cell Carcinoma and Its Clinical Significance

Combined Inhibition of PI3K and STAT3 signaling effectively inhibits bladder cancer growth

Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis.